scispace - formally typeset
S

Sarah Song

Researcher at University of Queensland

Publications -  18
Citations -  4754

Sarah Song is an academic researcher from University of Queensland. The author has contributed to research in topics: Breast cancer & CDKN2A. The author has an hindex of 13, co-authored 18 publications receiving 4027 citations. Previous affiliations of Sarah Song include Royal Brisbane and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Whole genomes redefine the mutational landscape of pancreatic cancer.

Nicola Waddell, +88 more
- 26 Feb 2015 - 
TL;DR: Genomic instability co-segregated with inactivation of DNA maintenance genes (BRCA1, BRCA2 or PALB2) and a mutational signature of DNA damage repair deficiency, and 4 of 5 individuals with these measures of defective DNA maintenance responded to platinum therapy.
Journal ArticleDOI

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin, +140 more
- 15 Nov 2012 - 
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
Journal ArticleDOI

Metastatic progression of breast cancer: insights from 50 years of autopsies.

TL;DR: Clonal heterogeneity of the primary tumour is important in developing metastatic propensity and the change in tumour phenotype during progression/colonization highlights the importance of sampling metastatic disease for optimal treatment strategies.
Journal ArticleDOI

Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression

TL;DR: Gene expression profiles were identified that molecules related to extracellular matrix (ECM) remodelling were differentially expressed between DCIS and IDC and it is proposed that these expression changes could be involved in facilitating the transition from in situ disease to invasive cancer and may thus mark a critical point in disease development.